BBOX – Black Box Ltd – Q4 FY26 Financial Results – 26-May-26

Black Box’s FY26 shows modest growth, stronger balance sheet, and improving pre‑exceptional profitability, but trade receivables nearly tripled. Margin re‑rating hinges on Technology Product Solutions turning accretive and exceptional charges easing. With negligible FCF and finance costs consuming two‑thirds of PBT, revenue acceleration and WC discipline are critical.

1–2 minutes


🔍 Observations

Topline

  • Revenue from operations grew 6% YoY (₹5,966 Cr → ₹6,322 Cr), driven primarily by System Integration (+5% YoY, ₹5,069 Cr → ₹5,326 Cr), which contributed 84% of FY26 revenue.
  • Q4FY26 revenue of ₹1,691 Cr was the strongest quarter, up 9.5% YoY vs Q4FY25 (₹1,545 Cr), signaling a second-half acceleration.
  • Technology Product Solutions grew 11% YoY (₹764 Cr → ₹847 Cr), a positive inflection despite persistent segment-level losses.

Bottomline

  • Reported PAT grew 6.2% YoY (₹205 Cr → ₹218 Cr), but effective tax rate spiked to 9% in FY26 vs 3.7% in FY25 due to prior-year deferred tax tailwinds; pre-tax profit grew a stronger 13% (₹212 Cr → ₹239 Cr).
  • Exceptional items consumed ₹62.85 Cr in FY26 (vs ₹65.69 Cr in FY25) — recurring in nature, structurally suppressing reported earnings by ~₹63 Cr annually.
  • Basic EPS grew modestly from ₹12.16 → ₹12.78, partially diluted by fresh equity issuance under share warrants.

Margins

  • Segment EBIT margin (Total segment results / Revenue): FY26 = 440.38 / 6,321.85 = 6.97% vs FY25 = 424.16 / 5,966.91 = 7.11% — marginal compression despite absolute EBIT growth.
  • Net profit margin held flat at ~3.4% (₹217.52 / ₹6,321.85 in FY26 vs ₹204.78 / ₹5,965.91 in FY25).
  • Finance costs rose 9% YoY (₹145 Cr → ₹158 Cr), consuming a rising share of operating profit and capping margin expansion.

Growth Trajectory

  • Two-year revenue run-rate is low-single-digit organic growth; the business is scaling but not re-rating — no step-change inflection visible in FY26.
  • Technology Product Solutions segment moved from ₹(32.72) Cr EBIT loss in FY25 to ₹(15.84) Cr in FY26 — loss halved, trajectory improving but not yet accretive.
  • Others segment EBIT grew from ₹15.20 Cr → ₹22.09 Cr (+45% YoY), smallest but fastest-improving contributor.
Continue reading “BBOX – Black Box Ltd – Q4 FY26 Financial Results – 26-May-26”

POWERINDIA – Hitachi Energy India – Q4 FY26 Financial Results – 25-May-26

Hitachi Energy India’s FY26 delivered 810 bps EBITDA margin expansion on scaling revenue, record ₹29,555 Cr backlog, and debt‑free balance sheet — a structural re‑rating story. Risks: WC intensity from receivables/inventory, geopolitical input costs, and execution on ballooning portfolio. Margin inflection with backlog momentum anchors compounding thesis.

1–2 minutes


🔍 Observations

Topline

  • Revenue from operations grew 27.6% YoY (₹6,384.9 Cr → ₹8,147.7 Cr), driven by strong execution across grid, data centre, and export orders.
  • Q4FY26 revenue of ₹2,754 Cr surged 46.2% YoY vs Q4FY25’s ₹1,883.7 Cr — indicating an accelerating exit run-rate.
  • Order backlog of ₹29,555 Cr (3.6x FY26 revenue) provides multi-year revenue visibility.

Bottomline

  • PAT jumped 157.2% YoY (₹384 Cr → ₹987.8 Cr); excluding the ₹54.2 Cr exceptional Labour Codes charge, underlying PBT growth is even sharper at 178% (₹516.4 Cr → ₹1,375.2 Cr).
  • Q4FY26 PAT of ₹330.5 Cr grew 79.7% YoY vs Q4FY25’s ₹183.9 Cr — bottomline acceleration is outpacing topline.
  • EPS nearly tripled YoY: ₹90.4 → ₹221.6 (basic), on an unchanged share count of 4.46 Cr shares.

Margins

  • EBITDA (PBT before exceptional + D&A + Finance costs): FY26 = ₹1,375.2 + ₹104.3 + ₹12.8 = ₹1,492.3 Cr; EBITDA margin = 18.3% vs FY25’s (₹516.4 + ₹91.4 + ₹45.2) / ₹6,384.9 = 10.2%. A 810 bps expansion.
  • Net profit margin: 12.1% in FY26 vs 6.0% in FY25 — a 610 bps improvement, confirming operating leverage is kicking in at scale.
  • Other income of ₹239.9 Cr (vs ₹57.2 Cr prior year) — largely interest income on the large cash pile — contributed meaningfully; strip this out and core operating margin improvement is still substantial.

Growth Trajectory

  • Revenue CAGR implied over one year is 27.6%; with Q4 alone clocking ₹2,754 Cr, annualised exit rate is ~₹11,000 Cr — suggesting FY27 consensus could see significant upgrades.
  • Order intake of ₹18,456.5 Cr in FY26 is 2.3x FY26 revenue — book-to-bill well above 2x, sustaining the growth flywheel.
  • Exports at 36.8% of Q4 order intake and geographic diversification (US, Europe, APAC) reduce India-concentration risk.
Continue reading “POWERINDIA – Hitachi Energy India – Q4 FY26 Financial Results – 25-May-26”

TECHNOE – Techno Electric & Engineering Company – Q4 FY26 Financial Results – 25-May-26

Techno Electric’s FY26 delivered strong topline scaling but margin compression and negative OCF reflect mid‑cycle project execution. Near‑debt‑free balance sheet and ₹22,500 Mn liquidity cushion mitigate stress. Re‑rating hinges on margin inflection — collections, billing cycles, and EBITDA recovery toward 21–22% as projects near completion.

1–2 minutes


🔍 Observations

Topline

  • Revenue surged 43.3% YoY (₹22,687 Mn → ₹32,516 Mn), reflecting strong EPC order execution acceleration in H2FY26.
  • Q4FY26 revenue of ₹10,100 Mn grew 23.8% YoY and 15.8% QoQ — execution velocity clearly stepped up into year-end.
  • Other income declined to ₹1,495 Mn from ₹1,600 Mn as the investment portfolio was partially liquidated to fund working capital.

Bottomline

  • PAT from continuing operations rose 18.7% YoY (₹3,781 Mn → ₹4,487 Mn), but lagged revenue growth significantly — a margin compression story.
  • EPS grew only 9.5% YoY (₹37.19 → ₹40.74 on total operations), dampened by the absence of discontinued-ops contribution in FY26 vs FY25.
  • Q4FY26 PAT of ₹1,145 Mn fell 14.9% YoY vs Q4FY25’s ₹1,346 Mn — lower base quarter profitability despite higher revenues.

Margins

  • EBITDA margin contracted ~320 bps YoY: 22.0% (FY25) → 18.8% (FY26), as materials cost scaled faster than revenue.
  • PAT margin (continuing ops) compressed from 16.7% to 13.8% — cost of materials consumed rose to 78.7% of revenue vs 76.8% in FY25.
  • Finance costs jumped 82.9% (₹105 Mn → ₹193 Mn) as short-term borrowings were deployed to bridge working capital gaps.

Growth Trajectory

  • Revenue CAGR is strong, but profit growth is decelerating — PAT grew 18.7% on a 43.3% revenue base, signalling margin dilution risk if mix or pricing doesn’t improve.
  • Discontinued operations contributed ₹282 Mn in FY26 vs ₹448 Mn in FY25 — a structurally fading tailwind.
  • Order execution is clearly scaling; the question is whether margin recovery follows as projects mature.
Continue reading “TECHNOE – Techno Electric & Engineering Company – Q4 FY26 Financial Results – 25-May-26”

RVNL – Rail Vikas Nigam – Q4 FY26 Financial Results – 25-May-26

RVNL’s FY26 shows earnings quality deterioration — topline flat, PAT down a third, and receivables surge turning cash‑generative EPC into cash consumer. Core railway pipeline intact, but re‑rating hinges on FY27 receivables recovery and margin inflection; until OCF turns positive, stock trades on order book narrative.

1–2 minutes


🔍 Observations

Topline

  • Revenue from operations grew a modest 2.5% YoY (₹19,923 Cr → ₹20,412 Cr), signalling execution pace rather than order-book constraints
  • Q4FY26 revenue of ₹6,696 Cr was the strongest quarter of the year, up 4.2% vs Q4FY25 — typical year-end project billings spike
  • Other income fell sharply 22.5% YoY (₹1,000 Cr → ₹775 Cr), dragging total income growth below operating revenue growth

Bottomline

  • Net profit collapsed 31.9% YoY (₹1,278 Cr → ₹871 Cr); EPS fell from ₹6.13 to ₹4.20
  • Q4FY26 PAT of ₹182 Cr was the weakest quarter — 60% below Q4FY25’s ₹455 Cr — a severe sequential and YoY deterioration
  • Tax rate improved marginally (22.4% vs 22.4% prior year), ruling out tax as the driver; the damage is entirely operational

Margins

  • Operating expense ratio (expense of operations / revenue from operations): FY26 = 92.8% vs FY25 = 92.5% — minimal worsening but leaves thin headroom
  • PBT margin compressed sharply: 5.8% in FY26 vs 8.3% in FY25 (₹1,181 Cr on ₹20,412 Cr revenue vs ₹1,646 Cr on ₹19,923 Cr)
  • Finance costs declined 23.1% YoY (₹545 Cr → ₹419 Cr) — the one material positive in the cost structure

Growth Trajectory

  • Revenue CAGR is decelerating; 2.5% topline growth on a government-capex-driven EPC business points to execution or award-conversion bottlenecks
  • Other income, which contributed ~5% of FY25 PBT, is structurally shrinking as cash balances are deployed or paid out as dividends
  • JV/associate profit share held flat at ~₹92–94 Cr — no meaningful delta from the equity investment portfolio
Continue reading “RVNL – Rail Vikas Nigam – Q4 FY26 Financial Results – 25-May-26”

DIVISLAB – Divi’s Laboratories – Q4 FY26 Financial Results – 23-May-26

Divi’s FY26 delivered topline growth with rare margin expansion in APIs, funded capex doubling via accruals on debt‑free balance sheet. Risks: ₹718 Cr inventory build — demand vs procurement clarity due H1FY27. Strong OCF, accelerating exit rate, and expanding margins keep structural case intact despite FCF compression.

1–2 minutes


🔍 Observations

Topline

  • Revenue from operations grew 12.8% YoY (₹9,360 Cr → ₹10,560 Cr), with Q4FY26 at ₹2,831 Cr — the strongest quarter of FY26, up 9.5% over Q4FY25’s ₹2,585 Cr.
  • Sequential revenue momentum held: Q2→Q3→Q4 progression of ₹2,604 Cr → ₹2,604 Cr → ₹2,831 Cr signals an accelerating exit rate into FY27.
  • Other income jumped 44% YoY (₹352 Cr → ₹507 Cr), driven by interest on FDs; operationally irrelevant but flatters total income.

Bottomline

  • Net profit grew 17.2% YoY (₹2,191 Cr → ₹2,568 Cr), outpacing revenue — positive operating leverage at work.
  • Q4FY26 PAT of ₹751 Cr was the highest quarterly print, up 13.4% over Q4FY25’s ₹662 Cr; sequential jump from ₹583 Cr reflects Q3’s one-time labour code charge of ₹74 Cr normalising out.
  • Basic EPS expanded from ₹82.53 to ₹96.75 — a 17.2% YoY improvement on an unchanged share count.

Margins

  • EBITDA (PBT ex-other income + depreciation + finance costs): FY26 = ₹3,462 – ₹507 + ₹463 + ₹23 = ₹3,441 Cr on revenue of ₹10,560 Cr → EBITDA margin 32.6% vs FY25: ₹2,916 – ₹352 + ₹402 + ₹2 = ₹2,968 Cr on ₹9,360 Cr → 31.7%. ~90 bps expansion YoY.
  • Net profit margin (PAT/Revenue from ops): FY26 = 2,568/10,560 = 24.3% vs FY25 = 2,191/9,360 = 23.4%. ~90 bps improvement.
  • Employee costs grew 16% YoY (₹1,243 Cr → ₹1,442 Cr) and material costs grew 14.6% (₹3,821 Cr → ₹4,378 Cr net of inventory change: ₹3,821–96 = ₹3,725 Cr FY25 vs ₹4,378–285 = ₹4,093 Cr FY26, +9.9%) — cost discipline preserved margin expansion.

Growth Trajectory

  • Revenue CAGR trajectory: 12.8% in FY26; combined with margin expansion, the earnings growth of 17.2% YoY demonstrates operating leverage materialising at scale.
  • CWIP nearly doubled (₹1,022 Cr → ₹2,113 Cr) and capex was ₹2,520 Cr in FY26 vs ₹1,438 Cr in FY25 — a 75% capex step-up signals management’s confidence in sustaining double-digit volume growth.
  • Total equity grew from ₹14,969 Cr to ₹16,761 Cr, entirely through retained earnings; the asset base expanded from ₹16,932 Cr to ₹20,033 Cr — 18.3% in one year.
Continue reading “DIVISLAB – Divi’s Laboratories – Q4 FY26 Financial Results – 23-May-26”

PAGEIND – Page Industries – Q4 FY26 Financial Results – 21-May-26

Page Industries’ FY26 shows structurally sound balance sheet and premium franchise, but traded‑goods mix compresses margins and inventory build in sub‑7% growth year clouds demand visibility. Q4’s 14.1% revenue growth offers re‑rating path if FY27 sustains momentum and inventory normalises into cash flow.

1–2 minutes


🔍 Observations

Topline

  • FY26 revenue grew 6.3% YoY (₹4,93,491L → ₹5,24,678L), modest for a premium innerwear franchise but directionally intact.
  • Q4FY26 revenue jumped 14.1% YoY (₹1,09,807L → ₹1,25,260L), signalling a strong close to the year.
  • Traded goods purchases surged 56% YoY (₹73,771L → ₹1,15,161L), indicating a significant mix shift toward outsourced/traded inventory.

Bottomline

  • FY26 net profit grew 4.8% YoY (₹72,914L → ₹76,382L), lagging revenue growth — cost pressures compressed operating leverage.
  • Q4FY26 PAT of ₹17,873L grew 9.0% YoY (vs ₹16,401L), a cleaner quarter absent the Q3 exceptional charge.
  • EPS expanded from ₹653.71 to ₹684.81, a 4.8% YoY gain on flat share capital — purely earnings-driven.

Margins

  • FY26 EBITDA (PBT + Finance costs + D&A): ₹1,02,534L + ₹4,978L + ₹10,663L = ₹1,18,175L on revenue of ₹5,24,678L → EBITDA margin of 22.5% vs FY25: ₹97,858L + ₹4,638L + ₹9,923L = ₹1,12,419L on ₹4,93,491L → 22.8%. Marginal 30bps compression.
  • Net profit margin: FY26 = ₹76,382L / ₹5,24,678L = 14.6% vs FY25 = ₹72,914L / ₹4,93,491L = 14.8%. Stable but gently declining.
  • Employee costs rose 14.8% YoY (₹82,150L → ₹94,294L), growing materially faster than revenue — the primary margin drag.

Growth Trajectory

  • 6.3% topline growth is below historical norms for Page Industries; the traded goods surge suggests channel/product mix changes rather than organic volume acceleration.
  • Q4 quarterly trend (14.1% YoY) is the strongest quarter of FY26 — momentum is improving into the new year.
  • Inventory build of ₹19,679L (cash flow basis) in a 6%-growth year is a caution flag on demand visibility.
Continue reading “PAGEIND – Page Industries – Q4 FY26 Financial Results – 21-May-26”

HINDALCO – Hindalco Industries – Q4 FY26 Financial Results – 22-May-26

Hindalco’s FY26 delivered ~10% pre‑exceptional earnings growth on 15% revenue jump, but debt rose ~56%, inventory ballooned 55%, and FCF turned negative amid capex bets. Novelis EBITDA/tonne recovery is the swing factor; FY26 is a transition year — watch Novelis margins, inventory normalization, and OCF recovery for re‑rating.

1–2 minutes


🔍 Observations

Topline

  • Consolidated revenue surged 15.3% YoY (₹2,38,496 Cr → ₹2,74,944 Cr), with Q4FY26 alone jumping 20.4% YoY (₹64,890 Cr → ₹78,133 Cr) — broadest quarterly run-rate in recent history.
  • Copper segment drove outsized topline contribution, growing 27.7% YoY (₹54,703 Cr → ₹69,838 Cr); Aluminium downstream accelerated 24.3% YoY (₹12,819 Cr → ₹15,938 Cr).
  • Novelis, the largest segment at 59% of revenue, grew a modest 12.3% YoY (₹1,45,068 Cr → ₹1,62,882 Cr) — volume/mix, not commodity tailwinds, likely driving it.

Bottomline

  • Reported PAT declined 16.3% YoY (₹16,002 Cr → ₹13,391 Cr), distorted entirely by exceptional charges of ₹6,963 Cr in FY26 vs. ₹879 Cr in FY25.
  • Pre-exceptional PBT grew 9.7% YoY (₹23,216 Cr → ₹25,459 Cr), confirming underlying earnings power is intact and expanding.
  • EPS (basic) compressed to ₹60.31 from ₹72.05 — optically weak, but exceptional-item-driven; core trajectory is positive.

Margins

  • Segment EBITDA expanded to ₹37,217 Cr from ₹35,162 Cr (+5.8% YoY); consolidated EBITDA (segment results + unallocable, pre-finance/D&A) at ₹38,097 Cr vs. ₹35,496 Cr (+7.3% YoY).
  • EBITDA margin on revenue from operations: 38,097 / 2,74,944 = 13.9% vs. 35,496 / 2,38,496 = 14.9% — 100 bps compression YoY, partly attributable to Copper’s lower-margin revenue mix growing fastest.
  • Aluminium upstream segment result improved to ₹18,884 Cr from ₹16,262 Cr (+16.1% YoY) — the highest-margin segment delivering the best absolute growth.

Growth Trajectory

  • Revenue CAGR implied over two years is healthy, but working capital consumption is accelerating disproportionately — a structural flag for FY27 free cash flow visibility.
  • Aluminium downstream, though small, grew 54.5% in segment results (₹633 Cr → ₹978 Cr) — early signs of downstream value-add monetisation.
  • Novelis segment result fell 4.6% YoY (₹15,242 Cr → ₹14,546 Cr) despite revenue growth — margin dilution at the most important subsidiary warrants monitoring.
Continue reading “HINDALCO – Hindalco Industries – Q4 FY26 Financial Results – 22-May-26”

EICHERMOT – Eicher Motors – Q4 FY26 Financial Results – 22-May-26

Eicher Motors’ FY26 delivered 24% revenue growth, ₹3,530 Cr FCF, near‑zero leverage, and VECV JV momentum. Risks: 150 bps PAT margin compression and Q4 revenue stall. Re‑rating now hinges on margin leverage from new platforms and global scale‑up; treasury earnings floor strong but RE must grow without dilution.

1–2 minutes


🔍 Observations

Topline

  • Revenue from operations crossed ₹23,408 Cr in FY26 vs ₹18,870 Cr in FY25 — 24.0% YoY growth, driven by Royal Enfield volume expansion and premiumisation
  • Q4FY26 revenue at ₹6,080 Cr vs ₹5,241 Cr in Q4FY25 — 16.0% YoY growth; sequentially flat vs Q3FY26 (₹6,114 Cr)
  • Other income (investment returns) rose to ₹1,487 Cr in FY26 from ₹1,305 Cr — meaningful contributor given the large treasury corpus

Bottomline

  • PAT grew 16.5% YoY to ₹5,515 Cr (FY26) from ₹4,734 Cr (FY25); Q4FY26 PAT at ₹1,520 Cr, up 11.6% vs Q4FY25 (₹1,362 Cr)
  • JV profit contribution (VECV) rose to ₹798 Cr in FY26 from ₹700 Cr — 14.0% YoY; Q4FY26 VECV share surged to ₹323 Cr vs ₹248 Cr in Q4FY25
  • Basic EPS expanded to ₹201.09 in FY26 from ₹172.76 in FY25 — 16.4% YoY growth

Margins

  • FY26 EBITDA (PBT before JV + D&A + Finance costs): ₹6,359.70 + ₹840.37 + ₹71.53 = ₹7,271.60 Cr on revenue of ₹23,408 Cr → EBITDA margin ~31.1% vs ~30.7% in FY25 (₹5,233.26 + ₹729.33 + ₹54.34 = ₹6,016.93 Cr / ₹18,870 Cr) — marginal expansion
  • Net profit margin (PAT / Revenue from ops): 5,515 / 23,408 = 23.6% vs 4,734 / 18,870 = 25.1% in FY25 — 150bps compression, partly from higher tax (effective rate rose from 20.2% to 22.3%)
  • Raw material + traded goods as % of revenue: (12,502 + 835 − 270) / 23,408 = 55.4% vs (9,953 + 507 − 164) / 18,870 = 54.8% — modest input cost inflation absorbed

Growth Trajectory

  • Revenue CAGR at 24% for FY26 points to strong demand; sequential flatness in Q4 warrants watching for volume plateau
  • PAT growth (16.5%) lagging revenue growth (24.0%) signals operating leverage not fully flowing through — cost base scaling faster than topline
  • VECV’s improving profit trajectory (14% YoY) adds earnings resilience via non-motorcycle diversification
Continue reading “EICHERMOT – Eicher Motors – Q4 FY26 Financial Results – 22-May-26”

SUNPHARMA – Sun Pharmaceutical Industries – Q4 FY26 Financial Results – 22-May-26

Sun Pharma’s FY26 delivered 11% topline growth with ~31.5% EBITDA margins, specialty pivot sustaining quality. PAT up 5% understates strength; underlying trajectory solid. Re‑rating hinges on specialty‑led margin inflection toward 34–35%. Risks: faster opex growth, acquisition integration, intangibles spike, and receivables build.

1–2 minutes


🔍 Observations

Topline

  • Revenue from operations grew 11.2% YoY (₹525,784 Mn → ₹584,620 Mn), driven by both domestic formulations and specialty/global generic expansion.
  • Q4FY26 revenue of ₹146,118 Mn grew 12.8% YoY vs Q4FY25 (₹129,588 Mn), though declined 5.9% QoQ from Q3FY26’s ₹155,205 Mn — seasonal softness, not structural.
  • Other operating revenues fell sharply (₹5,372 Mn → ₹2,419 Mn YoY), a ₹2,953 Mn headwind to topline largely absorbed by core revenue momentum.

Bottomline

  • Reported PAT grew 5.0% YoY (₹109,290 Mn → ₹114,794 Mn); adjusted for ₹13,075 Mn of exceptional items in FY26 vs ₹6,779 Mn in FY25, underlying PAT growth is broadly similar.
  • Tax outflow surged — effective tax rate on reported PBT rose from ~17.4% to ~26.0% — compressing PAT despite strong EBIT growth; a large one-off deferred tax reversal benefited FY25.
  • EPS grew modestly from ₹45.6 to ₹47.8 (basic), with no dilution — share count flat at ~2,399 Mn shares.

Margins

  • EBITDA (PBT before exceptional + Finance costs + D&A): FY26 = ₹151,189 + ₹3,389 + ₹29,379 = ₹183,957 Mn on revenue of ₹584,620 Mn → EBITDA margin ~31.5% vs FY25: ₹137,521 + ₹2,314 + ₹25,754 = ₹165,589 Mn on ₹525,784 Mn → 31.5%. Margins held flat despite R&D intensity rising.
  • Net profit margin: ₹114,794 / ₹584,620 = 19.6% vs ₹109,290 / ₹525,784 = 20.8% — 120 bps compression, driven entirely by tax normalisation.
  • R&D spend rose to ₹34,741 Mn (5.9% of revenue) vs ₹31,542 Mn (6.0%) — pipeline investment sustained without margin sacrifice.

Growth Trajectory

  • Three-year revenue compound implied by 11.2% topline growth and consistent specialty mix shift signals durable mid-teens USD revenue CAGR in global markets.
  • Employee costs grew 14.5% YoY (₹99,731 Mn → ₹114,189 Mn), outpacing revenue — talent investment for specialty scaling, but warrants monitoring.
  • Other expenses grew 13.3% YoY (₹167,718 Mn → ₹190,083 Mn) — faster than revenue, suggesting operating leverage yet to fully materialise.
Continue reading “SUNPHARMA – Sun Pharmaceutical Industries – Q4 FY26 Financial Results – 22-May-26”

TORNTPHARMA – Torrent Pharmaceuticals – Q4 FY26 Financial Results – 22-May-26

Torrent Pharma’s FY26 vaulted revenues past ₹13,900 Cr via acquisition, but net debt/EBITDA ~2.9x and ₹24,280 Cr intangibles suppress PAT. Core remains resilient with ₹2,346 Cr FCF and ~31% EBITDA margins. Re‑rating hinges on brand revenue scaling faster than amortisation; watch receivables and finance costs.

1–2 minutes


🔍 Observations

Topline

  • Revenue from ops grew 21.4% YoY (₹11,516 Cr → ₹13,980 Cr), reflecting the step-up from an acquired business consolidating into FY26 numbers.
  • Q4FY26 printed ₹4,197 Cr — +41.8% YoY and +27.1% QoQ — the sharpest quarterly outturn, indicating the full consolidation effect landed in Q4.
  • Other income turned negative in FY26 (–₹94 Cr vs +₹23 Cr), reflecting forex and hedging losses that clipped reported total income.

Bottomline

  • Net profit grew 11.9% YoY (₹1,911 Cr → ₹2,138 Cr), well below revenue growth — margin dilution from acquisition-linked D&A and finance costs.
  • Q4FY26 net profit collapsed to ₹364 Cr vs ₹498 Cr in Q4FY25 (–26.9% YoY), driven by ₹236 Cr finance costs, ₹508 Cr D&A, and ₹66 Cr exceptional charges in a single quarter.
  • Effective tax rate improved to 25.6% (from 28.5%), providing partial offset; without this, PAT growth would have been thinner still.

Margins

  • EBITDA margin contracted ~100 bps to 31.3% (FY26) from 32.3% (FY25) — operating leverage partly absorbed by employee cost growth of 21.2% YoY.
  • Net profit margin compressed 130 bps to 15.3%, squeezed by D&A surging 40.8% and finance costs up 52.8%.
  • Q4FY26 EBITDA margin held at 31.9% (vs 32.0% in Q4FY25) — the operational core is stable; below-EBITDA lines are where the dilution originates.

Growth Trajectory

  • Organic revenue growth is likely sub-15%; the headline 21.4% is acquisition-inflated — normalisation will depend on how fast the acquired portfolio integrates.
  • EPS grew 13.2% (₹56.47 → ₹63.92) despite no equity dilution — share count unchanged at 169.23 Cr shares — all growth is earnings-driven on the legacy base.
  • D&A will remain elevated for multiple years as ₹24,280 Cr of intangible assets amortise; this is the single biggest structural drag on reported PAT growth.
Continue reading “TORNTPHARMA – Torrent Pharmaceuticals – Q4 FY26 Financial Results – 22-May-26”